Discover why US index-tracking assets remain a strong buy amid robust earnings, falling oil prices, and rate cut optimism.

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...

It has taken eight years and $303 million in seed and three rounds of venture funding, but NextSilicon is today delivering ...

The data center as we know it is being reimagined as an “AI factory” – a power- and data-optimized plant that turns energy ...

An investment firm economist told Kansas pension system officials that Trump policies are expected to result in "a mild ...

CSX Corporation's business is turning north, with several market conditions, including coal & intermodal expansion. Learn ...

Praxis Precision Medicines has shared positive data from its Phase III Essential3 clinical trial program (NCT06087276) assessing ulixacaltamide in essential tremor (ET). Across two studies, the small ...

GenInnov Global Innovation Fund founder Nilesh Jasani counters today's doom and gloom environment when it comes to AI and the ...

Amazon Web Services experienced experiencing a huge global outage. While a fix was attempted, it seemed to have knocked out ...

PFRDA consults on adopting dual valuation (Accrual/MTM) for Government Securities in NPS/APY schemes to stabilize NAV, reduce ...

In a market dominated by speculation and short-term hype, few events have managed to command genuine global attention. Yet, ...

Most GenAI pilots flop, but with better security, oversight and smart integration, enterprises can finally turn experiments ...